Edad como predictor de la severidad de la COVID-19 en pacientes pediátricos: una cohorte retrospectiva en un hospital de referencia del Perú

Objective: To estimate the role of age as a predictor of COVID-19 severity in pediatric patients hospitalized with a COVID-19 diagnosis at a reference hospital in Peru. Materials and methods: A retrospective cohort study was conducted, including pediatric patients from one month old to less than 14 years of age, hospitalized between May 2020 and December 31, 2021, at the Edgardo Rebagliati-Martins National Hospital. The exposure variable was age, categorized in six-month intervals. The outcome variable was the severity of COVID-19, determined according to the severity criteria established in the EsSalud Clinical Practice Guidelines for the management of COVID-19 in pediatrics. Crude and adjusted relative risks (RR) were estimated, with their respective 95% confidence intervals (95% CI). Results: Three-hundred and thirty-one patients were analyzed, their median age was 94 months (7,8 years), and the male-to-female ratio was 1.23. Comorbidities were present in 59.5% of the patients, with neurological disorders being the most common (13.9%). Fatalities were 3.3% of the whole sample, and 63.6% of them were severe cases. Severe COVID-19 was found in 9.4% of the sample. In the adjusted regression model, increasing age was not found to be a predictor of reduced risk of COVID-19 severity (adjusted RR= 1.02; 95% CI 0.98-1.06). Conclusion: Our study did not find age as a predictor of COVID-19 severity in hospitalized pediatric patients. Future studies are recommended to further explore and contrast our findings.

Authors

Institutions

Publication Details

Journal
ACTA MEDICA PERUANA
Published
2024-12-30
DOI
https://doi.org/10.35663/amp.2024.413.3063
Primary Topic
COVID-19 Clinical Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Edad como predictor de la severidad de la COVID-19 en pacientes pediátricos: una cohorte retrospectiva en un hospital de referencia del Perú

Diego Urrunaga‐Pastor, Alvaro Quincho-Lopez, Lesly Chávez‐Rimache, Matilde Estupiñan-Vigil et al.
ACTA MEDICA PERUANA
COVID-19 Clinical Research Studies
article

Edad como predictor de la severidad de la COVID-19 en pacientes pediátricos: una cohorte retrospectiva en un hospital de referencia del Perú

Diego Urrunaga‐Pastor, Alvaro Quincho-Lopez, Lesly Chávez‐Rimache, Matilde Estupiñan-Vigil, Miguel Quispe-Chipana, Anthony Romero-Cerdán, Giancarlo Alvarado‐Gamarra, Daniel Jair Enriquez-Vera, Sara Chávez-Alvarado, Iris Vargas-Chávez, Jimena Saavedra-Diaz
article en

Abstract

Objective: To estimate the role of age as a predictor of COVID-19 severity in pediatric patients hospitalized with a COVID-19 diagnosis at a reference hospital in Peru. Materials and methods: A retrospective cohort study was conducted, including pediatric patients from one month old to less than 14 years of age, hospitalized between May 2020 and December 31, 2021, at the Edgardo Rebagliati-Martins National Hospital. The exposure variable was age, categorized in six-month intervals. The outcome variable was the severity of COVID-19, determined according to the severity criteria established in the EsSalud Clinical Practice Guidelines for the management of COVID-19 in pediatrics. Crude and adjusted relative risks (RR) were estimated, with their respective 95% confidence intervals (95% CI). Results: Three-hundred and thirty-one patients were analyzed, their median age was 94 months (7,8 years), and the male-to-female ratio was 1.23. Comorbidities were present in 59.5% of the patients, with neurological disorders being the most common (13.9%). Fatalities were 3.3% of the whole sample, and 63.6% of them were severe cases. Severe COVID-19 was found in 9.4% of the sample. In the adjusted regression model, increasing age was not found to be a predictor of reduced risk of COVID-19 severity (adjusted RR= 1.02; 95% CI 0.98-1.06). Conclusion: Our study did not find age as a predictor of COVID-19 severity in hospitalized pediatric patients. Future studies are recommended to further explore and contrast our findings.

ACTA MEDICA PERUANAVol. 41(3)
National University of San Marcos (PE), Universidad Privada San Juan Bautista (PE), Universidad Científica del Sur (PE), Universidad San Ignacio de Loyola (PE), Hospital Nacional Cayetano Heredia (PE), Instituto de Investigación Nutricional (PE)
Good health and well-being
Openalex Percentile: Top 70%
COVID-19 Clinical Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.